Release test results
99.608%HPLC purity · meets ≥ 99.5% spec
Mass-spec identityConfirmed · 10.04 mg
Related impurities (total)0.392%
Endotoxin<1.0 EU/mg
HPLC retention time5.29 min
MethodHPLC + LC-MS
ResultPass · meets spec
Lot record
CompoundPentadecapeptide
Presentation10 MG
Lot numberRGX-26-PENTADECAPEPTIDE-627
COA numberNS-2026-05222
Test date07 Sep 2026
Release date10 Sep 2026
Independent labNordicstar Labs
StatusSuperseded
Pentadecapeptide — lot history
| Lot | Presentation | Tested | HPLC purity | Status |
|---|---|---|---|---|
| RGX-26-PENTADECAPEPTIDE-1073 | 10 MG | Sep 8, 2026 | 99.645% | Current |
| RGX-26-PENTADECAPEPTIDE-728 | 5 MG | Sep 7, 2026 | 99.638% | Superseded |
| RGX-26-PENTADECAPEPTIDE-627 this lot | 10 MG | Sep 7, 2026 | 99.608% | Superseded |
| RGX-26-PENTADECAPEPTIDE-727 | 10 MG | Sep 6, 2026 | 99.722% | Superseded |
| RGX-26-PENTADECAPEPTIDE-628 | 5 MG | Sep 4, 2026 | 99.684% | Superseded |
| RGX-26-PENTADECAPEPTIDE-1072 | 5 MG | Sep 3, 2026 | 99.683% | Current |
!
Research use only
This lot record documents a research compound sold for laboratory use only — not for human or animal consumption. Results are as tested by Nordicstar Labs; retained samples are archived for five years. Research Use Agreement →